United States Securities and Exchange Commission · EDGAR Accession 0002042609-25-000007

Form C

Offering Statement — Regulation Crowdfunding
Issuer CIK 2042609
Raising via StartEngine Primary, LLC

Eliaz Therapeutics, Inc.

CorporationDEIncorporated 2015Santa Rosa, CAeliaztherapeutics.com
A

The Offering

as disclosed in this filing
Other (Class B Common Stock)
$5.56
$19,999
$2,490,574
March 9, 2026
Expired 97 days ago
$0max $2,490,574

Target is 1% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn increasingDebt / assets 845%5 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(954,869)(548,405)▼ burn
Total assets738,015803,385▼ 8%
Cash & equivalents32,8144,886▲ 572%
Accounts receivable00
Short-term debt2,046,0851,566,203▲ 31%
Long-term debt4,188,1863,782,811▲ 11%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.